Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

327.70
+4.011.24%
Post-market: 329.101.40+0.43%19:57 EDT
Volume:297.66K
Turnover:97.53M
Market Cap:19.72B
PE:35.58
High:329.18
Open:323.08
Low:322.69
Close:323.69
52wk High:330.75
52wk Low:249.57
Shares:60.18M
Float Shares:60.18M
Volume Ratio:1.41
T/O Rate:0.49%
Dividend:4.71
Dividend Rate:1.44%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:1.00
PE(LYR):7.89

Loading ...

Moderna (MRNA) Posts First Late Stage mRNA Cancer Vaccine Win In Melanoma

Simply Wall St.
·
6 hours ago

Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet

TIPRANKS
·
Yesterday

Merck & Company Soars on Breakthrough Cancer Vaccine Hopes

TIPRANKS
·
Yesterday

Broadcom Stock Headlines 3 Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Yesterday

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Yesterday

Moderna, ADI, Merck, EPR, TJX: Trending With Analysts

TIPRANKS
·
Yesterday

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Dow Jones
·
Yesterday

Top Stock Market Highlights of the Week: Sembcorp Industries, Singapore’s Big Three Banks, Moderna and CapitaLand Investment

The Smart Investor
·
Yesterday

Soon You Can Buy Medicare Advantage Plans at Costco. What You Need to Know.

Dow Jones
·
Yesterday

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Yesterday

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Johnson & Johnson Names New Vice President for Litigation

Reuters
·
Yesterday

Stocks Ex-Dividend August 25

Dow Jones
·
Yesterday

Goldman Sachs, Merck Share Gains Contribute to Dow's 500-Point Jump

Dow Jones
·
Yesterday

US Equity Indexes Lower This Week as Trump Threatens Major Economic War on Iran

MT Newswires Live
·
Yesterday

Merck Price Target Raised to $160.00/Share from $140.00 by Goldman Sachs

Dow Jones
·
Yesterday

UnitedHealth Group (UNH) Stock Looks Cheap On Value But Faces Risk On News

Simply Wall St.
·
Yesterday

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Yesterday

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Yesterday

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Yesterday